Konstantinos Chiotis

3.7k total citations · 1 hit paper
47 papers, 2.0k citations indexed

About

Konstantinos Chiotis is a scholar working on Physiology, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Konstantinos Chiotis has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Physiology, 29 papers in Psychiatry and Mental health and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Konstantinos Chiotis's work include Alzheimer's disease research and treatments (35 papers), Dementia and Cognitive Impairment Research (29 papers) and Medical Imaging Techniques and Applications (12 papers). Konstantinos Chiotis is often cited by papers focused on Alzheimer's disease research and treatments (35 papers), Dementia and Cognitive Impairment Research (29 papers) and Medical Imaging Techniques and Applications (12 papers). Konstantinos Chiotis collaborates with scholars based in Sweden, United Kingdom and United States. Konstantinos Chiotis's co-authors include Agneta Nordberg, Elena Rodriguez‐Vieitez, Antoine Leuzy, Laëtitia Lemoine, Ove Almkvist, Laure Saint‐Aubert, Anders Wall, Per‐Göran Gillberg, Stephen F. Carter and Irina Savitcheva and has published in prestigious journals such as Brain, Journal of Neurochemistry and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Konstantinos Chiotis

46 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau PET imaging in neurodegenerative tauopathies—still a challenge

2019 425 citations Antoine Leuzy, Konstantinos Chiotis et al. Molecular Psychiatry profile →

Peers

Countries citing papers authored by Konstantinos Chiotis

Since Specialization

Citations

This map shows the geographic impact of Konstantinos Chiotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantinos Chiotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantinos Chiotis more than expected).

Fields of papers citing papers by Konstantinos Chiotis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstantinos Chiotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantinos Chiotis. The network helps show where Konstantinos Chiotis may publish in the future.

Co-authorship network of co-authors of Konstantinos Chiotis

This figure shows the co-authorship network connecting the top 25 collaborators of Konstantinos Chiotis. A scholar is included among the top collaborators of Konstantinos Chiotis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstantinos Chiotis. Konstantinos Chiotis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuropathologic correlates of cognitive impairment in Alzheimer’s disease with discordant CSF biomarker profiles: co-pathologies in focus 2025 ·Acta Neuropathologica ·Κωνσταντίνος Ιωάννου, Richard J. Perrin, (unknown), (unknown), Antoine Leuzy, Konstantinos Poulakis, Dorota Religa, Elena Rodriguez‐Vieitez, Konstantinos Chiotis, (unknown)	0
2	Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics 2024 ·EBioMedicine ·(unknown), Konstantinos Chiotis, Marco Bucci, Irina Savitcheva, Anna Matton, Miia Kivipelto, Andreas Jeromin, (unknown), Guglielmo Di Molfetta, Nicholas J. Ashton, Kaj Blennow, Henrik Zetterberg, Agneta Nordberg	3
3	Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach 2024 ·Methods in molecular biology ·Elena Rodriguez‐Vieitez, Amit Kumar, (unknown), Κωνσταντίνος Ιωάννου, (unknown), Konstantinos Chiotis	6
4	Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer’s disease compared to comorbid cases; proof of concept in the ADNI study 2024 ·Molecular Psychiatry ·(unknown), Marco Bucci, Antonios Tzortzakakis, Irina Savitcheva, Agneta Nordberg, Konstantinos Chiotis, (unknown)	11
5	Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective 2023 ·Cells ·Igor C. Fontana, (unknown), (unknown), (unknown), (unknown), (unknown), Marco Bucci, Konstantinos Chiotis, Amit Kumar, Agneta Nordberg	16
6	Tracking reactive astrocytes in autosomal dominant Alzheimer disease with plasma GFAP and multi‐modal PET imaging 2023 ·Alzheimer s & Dementia ·Konstantinos Chiotis, Charlotte Johansson, Elena Rodriguez‐Vieitez, Josef Pannee, Nicholas J. Ashton, Kaj Blennow, Henrik Zetterberg, Caroline Graff, Agneta Nordberg	1
7	Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP 2023 ·Molecular Neurodegeneration ·Konstantinos Chiotis, Charlotte Johansson, Elena Rodriguez‐Vieitez, Nicholas J. Ashton, Kaj Blennow, Henrik Zetterberg, Caroline Graff, Agneta Nordberg	17
8	Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Konstantinos Chiotis, Alessandra Dodich, Marina Boccardi, Cristina Festari, Alexander Drzezga, Oskar Hansson, Rik Ossenkoppele, Giovanni B. Frisoni, Valentina Garibotto, Agneta Nordberg	10
9	Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline 2021 ·Molecular Psychiatry ·Marco Bucci, Konstantinos Chiotis, Agneta Nordberg, (unknown)	68
10	Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism 2020 ·Brain Connectivity ·Una Smailović, Thomas Koenig, Irina Savitcheva, Konstantinos Chiotis, Agneta Nordberg, Kaj Blennow, Bengt Winblad, Vesna Jelić	19
11	Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [18F]THK5317 PET 2019 ·NeuroImage Clinical ·My Jonasson, Anders Wall, Konstantinos Chiotis, Antoine Leuzy, Jonas Eriksson, Gunnar Antoni, Agneta Nordberg, Mark Lubberink	2
12	Tau PET imaging in neurodegenerative tauopathies—still a challenge breakdown → 2019 ·Molecular Psychiatry ·Antoine Leuzy, Konstantinos Chiotis, Laëtitia Lemoine, Per‐Göran Gillberg, Ove Almkvist, Elena Rodriguez‐Vieitez, Agneta Nordberg	425
13	Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Konstantinos Chiotis, Per Stenkrona, Ove Almkvist, В. А. Степанов, Daniel Ferreira, Ryosuke Arakawa, Akihiro Takano, Eric Westman, Andrea Varrone, Nobuyuki Okamura, Hitoshi Shimada, Makoto Higuchi, Christer Halldin, Agneta Nordberg	31
14	Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Stephen F. Carter, Konstantinos Chiotis, Agneta Nordberg, Elena Rodriguez‐Vieitez	43
15	Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 2017 ·Neurobiology of Aging ·Konstantinos Chiotis, Laure Saint‐Aubert, Marina Boccardi, Anton Gietl, Agnese Picco, Andrea Varrone, Valentina Garibotto, Karl Herholz, Flavio Nobili, Agneta Nordberg, Giovanni B. Frisoni, Bengt Winblad, Clifford R. Jack	48
16	Tau PET imaging: present and future directions 2017 ·Molecular Neurodegeneration ·Laure Saint‐Aubert, Laëtitia Lemoine, Konstantinos Chiotis, Antoine Leuzy, Elena Rodriguez‐Vieitez, Agneta Nordberg	204
17	Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia 2017 ·Molecular Psychiatry ·Konstantinos Chiotis, Laure Saint‐Aubert, Elena Rodriguez‐Vieitez, Antoine Leuzy, Ove Almkvist, Irina Savitcheva, My Jonasson, Mark Lubberink, A. Wall, Gunnar Antoni, Agneta Nordberg	81
18	Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease 2016 ·Brain ·Elena Rodriguez‐Vieitez, Laure Saint‐Aubert, Stephen F. Carter, Ove Almkvist, Karim Farid, Michael Schöll, Konstantinos Chiotis, Steinunn Þórðardóttir, Caroline Graff, Anders Wall, Bengt Långström, Agneta Nordberg	208
19	Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology 2016 ·Journal of Nuclear Medicine ·My Jonasson, Anders Wall, Konstantinos Chiotis, Laure Saint‐Aubert, Helena Wilking, (unknown), (unknown), Alf Thibblin, Jonas Eriksson, Jens Sørensen, Gunnar Antoni, Agneta Nordberg, Mark Lubberink	47
20	Comparison of Early-Phase ¹¹C-Deuterium-l-Deprenyl and ¹¹C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease 2016 ·Journal of Nuclear Medicine ·Elena Rodriguez‐Vieitez, Stephen F. Carter, Konstantinos Chiotis, Laure Saint‐Aubert, Antoine Leuzy, Michael Schöll, Ove Almkvist, Anders Wall, Bengt Långström, Agneta Nordberg	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact